/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Amgen Inc. (AMGN) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 57.21\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n -0.25\n\n (-0.44%)\n\n \n\n \n\n \n\n \n\n Volume: 0\n\n \n\n \n\n\n\n 4:00 PM EST Feb 9, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
August 13,2009
\n \n
Close: \n 64.76\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
April 22,2009
\n \n
Close: \n 44.96\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
57.21
\n 		\n\n \n \n \n
Change $
\n \n 0.25\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 0.44%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
57.10
\n 		\n \n \n \n\n
Bid Size
1000
\n 		\n \n \n \n
Ask
57.22
\n\n 		\n \n \n \n
Ask Size
200
\n
\n \n \n \n
Open
58.24
\n 		\n \n \n \n
High
58.40
\n 		\n\n \n \n \n
Low
56.70
\n 		\n \n\n \n \n
Prev Close
57.46
\n
\n \n\n \n \n
Last Trade
2/9/10
\n 		\n \n \n \n
Volume
0
\n 		\n \n \n \n
\n
52 Wk Hi
64.76
\n 		\n\n \n \n \n
52 Wk Low
44.96
\n
\n \n\n \n \n
Market Cap
57.9 b
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
1,012,138,434
\n 		\n \n \n \n
EPS (TTM)
4.51
\n 		\n \n \n \n\n
PE Ratio
12.70
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
Nasdaq Global Select (NGS)
\n
\n
\n
\n
\n
\n \n
Exchange
NGS
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Amgen Inc.\n\n \n\n  (AMGN) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for AMGN\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Feb 08, 2010
\n\n \n\n\n\n
6:20 PM\n\n\n\n Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 29, 2010
\n\n \n\n\n\n
9:00 AM\n\n\n\n Liberty Analytics Co. Initiates Independent Research Coverage on Amgen - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jan 26, 2010
\n\n \n\n\n\n
3:17 PM\n\n\n\n Amgen Donates $615,000 to Support International Medical Corps' Haiti Earthquake Disaster Relief Efforts - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jan 25, 2010
\n\n \n\n\n\n
4:08 PM\n\n\n\n Amgen¿s Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share Increased 8 Percent to $4.91 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 21, 2010
\n\n \n\n\n\n
9:01 AM\n\n\n\n Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jan 20, 2010
\n\n \n\n\n\n
4:13 PM\n\n\n\n Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 14, 2010
\n\n \n\n\n\n
12:58 PM\n\n\n\n Amgen Donates $2 Million, Establishes Earthquake Relief Program - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jan 12, 2010
\n\n \n\n\n\n
6:10 AM\n\n\n\n MedGenesis Announces Agreements With Amgen and Biovail - Marketwire Canada
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 07, 2010
\n\n \n\n\n\n
4:34 PM\n\n\n\n Amgen to Present at the 28th Annual JP Morgan Healthcare Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jan 06, 2010
\n\n \n\n\n\n
9:02 AM\n\n\n\n Generex: a Year in Review; Setting the Stage for a Year of Progress - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 22, 2009
\n\n \n\n\n\n
4:04 PM\n\n\n\n Amgen Resolves EPO Patent Dispute With Roche - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Dec 18, 2009
\n\n \n\n\n\n
4:41 PM\n\n\n\n Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines - PR Newswire
7:49 AM\n\n\n\n Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union - PR Newswire
7:49 AM\n\n\n\n Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union - PR Newswire
7:06 AM\n\n\n\n Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 17, 2009
\n\n \n\n\n\n
9:10 AM\n\n\n\n Emerging Growth Stock Alert for Thursday, December 17, 2009: ARYC -- Arrayit Diagnostics to Bring Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 and Revenues Could Be Substantial! - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 15, 2009
\n\n \n\n\n\n
8:48 AM\n\n\n\n Santa's Identity Verified via Digital Identity-Focused Holiday Greeting From SAFE-BioPharma - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Dec 14, 2009
\n\n \n\n\n\n
6:15 PM\n\n\n\n Array BioPharma and Amgen Partner in Type 2 Diabetes - PR Newswire
6:15 PM\n\n\n\n Array BioPharma and Amgen Partner in Type 2 Diabetes - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 10, 2009
\n\n \n\n\n\n
1:30 PM\n\n\n\n Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care - PR Newswire
\n\n More News for AMGN >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");